Therefore, it can be hypothesized that future investigations using specific antagonists for chemokines, for instance using antagonist for CXCL10 in nephropathy, can open an avenue to development of molecular therapy of polyomaviruses related disorders. The gene discussed is CXCL10; the disease is kidney disorder.